Assessment of De-Escalation to a Low Potency Single Antiplatelet Therapy Guided by Genetics vs High Potency Single Antiplatelet Therapy to Neutralize Bleeding After an Acute Coronary Syndrome

Condition:   MYOCARDIAL INFARCTION Intervention:   Other: single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing. Sponsors:   Assistance Publique - Hôpitaux de Paris;   Fonds de Dotation ACTION Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials